U.S. Retail Distributors Stock News

If you are wondering whether AT&T's current share price still offers value, you are not alone. This article is built to help you make sense of what the market might be pricing in. Over the last week AT&T returned 0.4%, while the return over 30 days was a 4.3% decline and the year to date return stands at a 3.9% decline, set against a 1 year return of 8.4%, 3 year return of 39.6% and 5 year return of 47.2% based on a last close of US$23.59. Recent price moves have come alongside ongoing...

Matador Resources (MTDR) has been drawing attention after recent share price moves, with the stock closing at $42.94. Investors are weighing its mixed return profile against current earnings and revenue figures. See our latest analysis for Matador Resources. That recent close at $42.94 comes after a 9.23% 90 day share price return, while the 1 year total shareholder return of 27.64% decline contrasts with a 199.92% gain over five years. This suggests potential long term momentum alongside...

SoundHound AI (NasdaqGM:SOUN) has partnered with Bridgepointe Technologies to expand enterprise use of its AI agent and IT automation platforms. The partnership targets more than 12,000 Bridgepointe client companies across sectors including hospitality, automotive, and retail. The collaboration focuses on deploying SoundHound’s Amelia 7 AI agent for customer interaction and its Autonomics platform for IT operations automation. For investors tracking NasdaqGM:SOUN, this move comes with the...

Akamai Technologies (NasdaqGS:AKAM) is partnering with Deutsche Telekom Security to deliver managed cybersecurity services for critical industries in Europe. The offering includes API lifecycle management, proactive API security, incident management, and Guardicore Segmentation services. The collaboration is already in use at a major German state bank, highlighting early adoption in highly regulated financial services. Akamai, known for its content delivery and security offerings, is...

CDW (CDW) has drawn attention after recent trading, with the share price at $126 and returns over the past year and past 3 months both in negative territory. Investors may be reassessing expectations. See our latest analysis for CDW. The recent 1 month share price return of a 9.16% decline and 3 month share price return of a 20.33% decline sit alongside a 1 year total shareholder return of a 34.45% decline, which points to fading momentum as investors reassess CDW's risk and growth...

Rezolve AI (RZLV) is back in focus after closing an oversubscribed US$250 million registered direct equity financing with institutional investors, paired with ambitious revenue guidance targets for 2025 and 2026. See our latest analysis for Rezolve AI. The recent financing and bold revenue guidance have come against a volatile trading backdrop, with Rezolve AI’s share price at US$3.14 after a 32% 7-day share price return decline, a 7.9% 30-day share price return gain and a 3-year total...

Gevo (GEVO) is in focus after its North Dakota carbon capture facility issued more than 500,000 engineered carbon removal certificates, received an A rating from BeZero Carbon, and appointed Alex Clayton as Chief Carbon Officer. See our latest analysis for Gevo. Gevo’s recent carbon removal milestone and leadership changes have arrived alongside a 6.3% 1 day share price return and an 8.96% 7 day share price return. However, the 90 day share price return of an 11.34% decline suggests momentum...

If you are wondering whether Brookdale Senior Living's share price still offers value after a strong run, this article walks through what the current market price might be implying about the company. The stock last closed at US$12.95, with returns of 6.1% over 7 days, 18.9% over 30 days, 19.5% year to date, 163.2% over 1 year, 339.0% over 3 years, and 162.1% over 5 years, which has put it firmly on many investors' radar. Recent coverage around Brookdale Senior Living has focused on its...

Live Oak Bancshares reported past full-year 2025 results showing net interest income of US$448.36 million and net income of US$105.87 million, with earnings per share rising from the prior year as net charge-offs in the fourth quarter fell to US$13.74 million from US$33.57 million. Management pointed to record loan production, strong deposit growth, and expanding small-dollar SBA lending and technology investments as key drivers of this improved performance and operational efficiency. Next,...

What recent performance says about Paramount Skydance Paramount Skydance (PSKY) has drawn fresh attention after a recent stretch of weaker returns, with the stock down about 15% over the past month and roughly 30% over the past 3 months. At a last close of US$11.70, the company shows a 1 year total return of about 7%, but a 3 year total return near a 46% decline and a 5 year total return near a 73% decline. See our latest analysis for Paramount Skydance. Paramount Skydance’s recent 30 day...

If you are trying to figure out whether RH at around US$228 per share looks like a bargain or a value trap, it helps to first step back and look at what the recent share price has been telling you. The stock has seen mixed returns, with a 1.9% decline over the last 7 days, a 24.8% gain over the last 30 days, an 18.1% gain year to date, but also a 45.5% decline over 1 year, a 26.5% decline over 3 years and a 52.0% decline over 5 years. These swings suggest sentiment around RH has shifted more...

KKR (KKR) is back in focus after reports that it is on track to exceed a $20b target for its Americas buyout fund, with investors committing enough capital to approach a record hard cap. See our latest analysis for KKR. Despite the fundraising headlines, KKR’s recent trading has been softer. The 7 day share price return is 7.74% and the 30 day share price return is 7.29% from the latest close of $121.25. The 1 year total shareholder return of 26.33% contrasts with a much stronger 3 year and 5...

Event context and recent share performance Fortune Brands Innovations (FBIN) has been drawing attention after recent share price swings, including a 3.6% decline over the past day and a 5.2% drop over the past week. Even with that short term pressure, the stock shows a gain over the past month and past 3 months, alongside reported annual revenue of US$4.49b and net income of US$327.5m. These figures give investors concrete data to assess. See our latest analysis for Fortune Brands...

In January 2026, Sovereign AI announced it had selected Accenture and Palantir to help build and scale next-generation, sovereign-grade AI data centers across Europe, the Middle East, and Africa, powered by Dell AI Factory and NVIDIA technology and designed for government and commercial use. This mandate underscores how Accenture is positioning itself at the center of sovereign AI infrastructure, aligning with its research showing rising European investment in sovereign AI solutions. Next,...

In recent months, Applied Materials has reported stronger-than-expected quarterly results, extended its multi‑year growth streak, and highlighted rising demand for AI-related semiconductor equipment ahead of its February 12, 2026 earnings call. What stands out is how a concentrated wave of upbeat analyst research, focused on wafer fabrication equipment demand and AI chip investment, has rapidly reshaped expectations around Applied Materials’ role in the semiconductor supply chain. We’ll now...

Humana (NYSE:HUM) has partnered with Atlas Oncology to support cancer care for Medicare Advantage members. The collaboration focuses on care coordination, patient support, and quality of life for oncology patients in Humana’s Medicare Advantage plans. The new model aims to address both clinical and psychosocial needs for Medicare beneficiaries in covered regions. Humana, trading at around $266.5 per share, has seen mixed share price performance, including a 2.5% decline over the past week...

In past trading, Flex moved after the US administration under President Trump suspended planned tariffs on European allies, easing immediate transatlantic trade tensions and improving market sentiment. This policy shift reduced near-term uncertainty for globally exposed manufacturers like Flex, highlighting how political decisions can quickly reshape perceived operational and supply-chain risks. We’ll now examine how the easing of tariff concerns influences Flex’s investment narrative and...

In recent days, Alignment Healthcare appointed former Optum Insight technology leader Adnan Mansour as chief digital officer to unify its technology and information functions and further scale its AI-powered AVA platform. These leadership and technology upgrades come as Alignment Healthcare reports double-digit membership growth and earns a spot on Fortune’s 2026 World’s Most Admired Companies list, underscoring peer recognition of its Medicare Advantage model. We’ll now examine how the...

Brown & Brown (NYSE:BRO) has launched a fully integrated, all-lines national healthcare practice. The new platform brings together more than 140 professionals to serve healthcare organizations across the US. The practice is designed to offer end-to-end risk management and insurance solutions tailored to healthcare needs. For investors watching NYSE:BRO, this move comes as the stock trades around $79.18, with a mixed performance profile. The shares show a 40.2% return over 3 years and 90.0%...

Liberty Latin America (LILA) has caught investor attention after recent trading left the shares around $7.57, with mixed return patterns over the past month and past 3 months raising fresh questions about its valuation. See our latest analysis for Liberty Latin America. That 1-day share price return of 2.95% and 90-day share price decline of 11.98% sit alongside a year-to-date share price gain of 4.27% and a 1-year total shareholder return of 9.87%. Taken together, these figures suggest...

Oscar Health (OSCR) is back in focus after Blue Square Asset Management disclosed it sold its entire stake, while Barclays shifted its rating higher and left investors weighing mixed institutional and analyst signals. See our latest analysis for Oscar Health. The market reaction to Blue Square’s exit and mixed quarterly results comes after a choppy year, with a 30 day share price return of 5.02% but a 1 year total shareholder return decline of 5.83%, and a very large 3 year total shareholder...

RPM International (RPM) is back in focus after JPMorgan upgraded the stock and the company outlined about US$100 million in annual SG&A savings, alongside guidance for modest sales and adjusted EBIT growth. See our latest analysis for RPM International. At a share price of US$109.48, RPM has a modest 30 day share price return of 3.49%, while its 1 year total shareholder return of 11.75% decline contrasts with a 31.33% gain over three years and 45.37% over five years. This suggests longer term...

In Q4 2025, Voya Investment Management’s Voya MidCap Opportunities Fund cited Vera Therapeutics as a top contributor after positive phase three kidney disease trial results and progress in AI-enabled drug discovery. This combination of clinical success and alignment with an institutional investor’s process has put Vera’s science and platform squarely in the spotlight for active managers. Next, we’ll examine how Vera’s phase three success and AI-enabled drug discovery approach shape the...

Northrop Grumman secured new multi million dollar U.S. defense contracts for an advanced lightweight torpedo program for the Navy. The company also won a Marine Corps MUX TACAIR collaborative combat aircraft contract focused on unmanned and autonomous systems integration. These awards extend Northrop Grumman’s role in next generation military technologies across maritime and aerial domains. For investors tracking NYSE:NOC, these contract wins add context to a share price of $672.95 and...